Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127598521 | 12759852 | 1 | I | 20160815 | 20160906 | 20160919 | 20160919 | EXP | IT-MINISAL02-373475 | IT-MYLANLABS-2016M1038132 | MYLAN | 0.00 | Y | 0.00000 | 20160919 | MD | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127598521 | 12759852 | 1 | SS | MIRTAZAPINE. | MIRTAZAPINE | 1 | Oral | 1 DF, QD | U | U | 0 | 1 | DF | TABLET | QD | ||||
| 127598521 | 12759852 | 2 | PS | SERTRALINE | SERTRALINE HYDROCHLORIDE | 1 | Oral | 50 MG, QD | U | U | 78626 | 50 | MG | TABLET | QD | ||||
| 127598521 | 12759852 | 3 | SS | SONGAR | TRIAZOLAM | 1 | Oral | 16 GTT, QD | U | U | 0 | 16 | GTT | ORAL DROPS, SOLUTION | QD | ||||
| 127598521 | 12759852 | 4 | C | ISOPTIN | VERAPAMIL HYDROCHLORIDE | 1 | Oral | UNK | D | 0 | |||||||||
| 127598521 | 12759852 | 5 | C | MOVICOL | POLYETHYLENE GLYCOL 3350POTASSIUM CHLORIDESODIUM BICARBONATESODIUM CHLORIDE | 1 | Oral | UNK | D | 0 | |||||||||
| 127598521 | 12759852 | 6 | C | CLEXANE | ENOXAPARIN SODIUM | 1 | Subcutaneous | UNK | D | 0 | |||||||||
| 127598521 | 12759852 | 7 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Oral | 40 MG | D | 0 | 40 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127598521 | 12759852 | 1 | Depression |
| 127598521 | 12759852 | 2 | Depression |
| 127598521 | 12759852 | 3 | Depression |
| 127598521 | 12759852 | 4 | Product used for unknown indication |
| 127598521 | 12759852 | 5 | Product used for unknown indication |
| 127598521 | 12759852 | 6 | Product used for unknown indication |
| 127598521 | 12759852 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127598521 | 12759852 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127598521 | 12759852 | Dysarthria | |
| 127598521 | 12759852 | Sopor |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127598521 | 12759852 | 1 | 20160101 | 0 | ||
| 127598521 | 12759852 | 2 | 20160101 | 0 | ||
| 127598521 | 12759852 | 3 | 20160101 | 0 |